Zynex Inc Stock Today
| ZYXI Stock | USD 8.35 0.02 0.24% |
Performance3 of 100
| Odds Of DistressLess than 1
|
Zynex is trading at 8.35 as of the 28th of November 2024. This is a 0.24 percent increase since the beginning of the trading day. The stock's open price was 8.33. Zynex has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Zynex Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 31st of December 2002 | Category Healthcare | Classification Health Care |
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. The company has 31.85 M outstanding shares of which 4.83 M shares are at this time shorted by private and institutional investors with about 46.66 trading days to cover. More on Zynex Inc
Moving against Zynex Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Zynex Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Thomas Sandgaard | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Health Care, Health Care Equipment & Supplies, Medical Distribution, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsZynex can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zynex's financial leverage. It provides some insight into what part of Zynex's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zynex Inc (ZYXI) is traded on NASDAQ Exchange in USA. It is located in 9655 Maroon Circle, Englewood, CO, United States, 80112 and employs 1,100 people. Zynex is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 265.27 M. Zynex Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 31.85 M outstanding shares of which 4.83 M shares are at this time shorted by private and institutional investors with about 46.66 trading days to cover.
Zynex Inc currently holds about 23.53 M in cash with 17.76 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63.
Check Zynex Probability Of Bankruptcy
Ownership AllocationZynex Inc retains a total of 31.85 Million outstanding shares. Zynex Inc owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Zynex Ownership Details
Zynex Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Rice Hall James & Associates, Llc | 2024-09-30 | 230.7 K | |
| Two Sigma Advisers, Llc | 2024-06-30 | 210.1 K | |
| Marshall Wace Asset Management Ltd | 2024-06-30 | 209.9 K | |
| Bank Of New York Mellon Corp | 2024-06-30 | 192.8 K | |
| D. E. Shaw & Co Lp | 2024-09-30 | 171.2 K | |
| Northern Trust Corp | 2024-09-30 | 158.5 K | |
| Janney Montgomery Scott Llc | 2024-09-30 | 144.4 K | |
| Renaissance Technologies Corp | 2024-09-30 | 133.6 K | |
| Congress Asset Management Company, Llp | 2024-09-30 | 116 K | |
| Blackrock Inc | 2024-06-30 | 1.2 M | |
| Vanguard Group Inc | 2024-09-30 | 1.2 M |
Zynex Historical Income Statement
Zynex Stock Against Markets
Zynex Corporate Management
| Anna Lucsok | Chief Officer | Profile | |
| Dave Anttila | Director HR | Profile | |
| Daniel Moorhead | Chief Officer | Profile | |
| Daniel CPA | Chief Officer | Profile | |
| Steve Fox | Executive Sales | Profile | |
| Chelle Burkleo | VP Sales | Profile |
Already Invested in Zynex Inc?
The danger of trading Zynex Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zynex is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zynex. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zynex Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 0.14 | Revenue Per Share 5.984 | Quarterly Revenue Growth 0.001 | Return On Assets 0.0399 |
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.